Palatin Technologies
PTN
#9998
Rank
S$41.92 M
Marketcap
S$24.63
Share price
-9.61%
Change (1 day)
2,098.69%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$6.57 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$8.84 Million. In 2024 the company made an earning of -S$34.75 Million, an increase over its 2023 earnings that were of -S$41.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.57 Million-81.1%
2024 -S$34.75 Million-16.9%
2023 -S$41.82 Million5.99%
2022 -S$39.46 Million-13.7%
2021 -S$45.72 Million33.25%
2020 -S$34.31 Million-172.11%
2019 S$47.57 M2352.33%
2018 S$1.94 M-94.13%
2017 S$33.05 M-154.92%
2016 -S$60.2 Million3.67%
2015 -S$58.07 Million878%
2014 -S$5.94 Million-72.64%
2013 -S$21.7 Million-33.11%
2012 -S$32.44 Million77.71%
2011 -S$18.26 Million
2003 -S$30.91 Million29.93%
2002 -S$23.79 Million36.18%
2001 -S$17.47 Million
1999 -S$14.5 Million6.04%
1998 -S$13.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-S$15.49 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$38.04 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.75 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$65.2 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$86.16 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.78 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.66 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.88 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK